Gary N. W. Leung

743 total citations
50 papers, 580 citations indexed

About

Gary N. W. Leung is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Animal Science and Zoology. According to data from OpenAlex, Gary N. W. Leung has authored 50 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Molecular Biology and 12 papers in Animal Science and Zoology. Recurrent topics in Gary N. W. Leung's work include Hormonal and reproductive studies (24 papers), Pharmacological Effects and Assays (11 papers) and Muscle metabolism and nutrition (8 papers). Gary N. W. Leung is often cited by papers focused on Hormonal and reproductive studies (24 papers), Pharmacological Effects and Assays (11 papers) and Muscle metabolism and nutrition (8 papers). Gary N. W. Leung collaborates with scholars based in China, Japan and United States. Gary N. W. Leung's co-authors include Terence S. M. Wan, Wai-Him Kwok, David K.K. Leung, Emmie N. M. Ho, April S. Y. Wong, Jenny K. Y. Wong, Hubert Po‐on Tang, Henry Ν. C. Wong, Masayuki Yamada and Nola H. Yu and has published in prestigious journals such as Journal of Chromatography A, Analytica Chimica Acta and Analytical and Bioanalytical Chemistry.

In The Last Decade

Gary N. W. Leung

47 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary N. W. Leung China 15 287 172 143 121 100 50 580
Gerd Sigmund Germany 15 387 1.3× 189 1.1× 121 0.8× 148 1.2× 132 1.3× 24 673
Mônica Costa Padilha Brazil 13 220 0.8× 122 0.7× 77 0.5× 93 0.8× 100 1.0× 42 433
Francesco Molaioni Italy 11 214 0.7× 100 0.6× 92 0.6× 90 0.7× 64 0.6× 20 364
David K.K. Leung China 14 311 1.1× 173 1.0× 202 1.4× 83 0.7× 105 1.1× 24 560
Dorota Kwiatkowska Poland 13 248 0.9× 103 0.6× 94 0.7× 160 1.3× 62 0.6× 51 485
L Avois Switzerland 8 266 0.9× 82 0.5× 71 0.5× 118 1.0× 88 0.9× 9 459
James Scarth United Kingdom 14 320 1.1× 80 0.5× 161 1.1× 119 1.0× 112 1.1× 36 535
Moutian Wu China 13 94 0.3× 139 0.8× 97 0.7× 35 0.3× 98 1.0× 18 453
Carine Schweizer Switzerland 11 422 1.5× 108 0.6× 160 1.1× 192 1.6× 99 1.0× 12 559
W. Schänzer Germany 8 742 2.6× 227 1.3× 270 1.9× 157 1.3× 145 1.4× 10 907

Countries citing papers authored by Gary N. W. Leung

Since Specialization
Citations

This map shows the geographic impact of Gary N. W. Leung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary N. W. Leung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary N. W. Leung more than expected).

Fields of papers citing papers by Gary N. W. Leung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary N. W. Leung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary N. W. Leung. The network helps show where Gary N. W. Leung may publish in the future.

Co-authorship network of co-authors of Gary N. W. Leung

This figure shows the co-authorship network connecting the top 25 collaborators of Gary N. W. Leung. A scholar is included among the top collaborators of Gary N. W. Leung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary N. W. Leung. Gary N. W. Leung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Ito, Hideki, et al.. (2023). Evaluation of plasma and urine pharmacokinetics of tranexamic acid for equine medication control. Journal of Veterinary Pharmacology and Therapeutics. 47(1). 21–27. 1 indexed citations
6.
So, Yat‐Ming, Jenny K. Y. Wong, Emmie N. M. Ho, et al.. (2021). Comprehensive metabolic study of IOX4 in equine urine and plasma using liquid chromatography/electrospray ionization Q Exactive high‐resolution mass spectrometer for the purpose of doping control. Drug Testing and Analysis. 14(2). 233–251. 8 indexed citations
7.
Leung, Gary N. W., et al.. (2021). Establishment of a post‐race biomarkers database and application of pathway analysis to identify potential biomarkers in post‐race equine plasma. Drug Testing and Analysis. 14(5). 915–928. 7 indexed citations
8.
Kwok, Karen Y., Wai-Him Kwok, Gary N. W. Leung, et al.. (2020). Detection of bioactive peptides including gonadotrophin‐releasing factors (GnRHs) in horse urine using ultra‐high performance liquid chromatography–high resolution mass spectrometry (UHPLC/HRMS). Drug Testing and Analysis. 12(9). 1274–1286. 17 indexed citations
9.
Wong, Jenny K. Y., Ho‐Man Chan, Karen Y. Kwok, et al.. (2020). A high‐throughput and broad‐spectrum screening method for analysing over 120 drugs in horse urine using liquid chromatography–high‐resolution mass spectrometry. Drug Testing and Analysis. 12(7). 900–917. 12 indexed citations
10.
Kwok, Wai-Him, et al.. (2019). Administration study of recombinant human relaxin‐2 in horse for doping control purpose. Drug Testing and Analysis. 12(3). 361–370. 3 indexed citations
11.
Wong, Jenny K. Y., et al.. (2017). Doping control analysis of lithium in horse urine and plasma by inductively coupled plasma mass spectrometry. Drug Testing and Analysis. 9(9). 1407–1411. 5 indexed citations
12.
Wong, April S. Y., Gary N. W. Leung, David K.K. Leung, & Terence S. M. Wan. (2016). Doping control analysis of anabolic steroids in equine urine by gas chromatography‐tandem mass spectrometry. Drug Testing and Analysis. 9(9). 1320–1327. 12 indexed citations
13.
Kwok, Wai-Him, et al.. (2013). Doping control analysis of seven bioactive peptides in horse plasma by liquid chromatography–mass spectrometry. Analytical and Bioanalytical Chemistry. 405(8). 2595–2606. 33 indexed citations
14.
Kwok, Wai-Him, et al.. (2010). Screening of drugs in equine plasma using automated on-line solid-phase extraction coupled with liquid chromatography–tandem mass spectrometry. Journal of Chromatography A. 1217(19). 3289–3296. 26 indexed citations
15.
Ho, Emmie N. M., David K.K. Leung, Gary N. W. Leung, et al.. (2009). Aminorex and rexamino as metabolites of levamisole in the horse. Analytica Chimica Acta. 638(1). 58–68. 37 indexed citations
16.
Ho, Emmie N. M., David K.K. Leung, Gary N. W. Leung, et al.. (2007). Metabolic studies of mesterolone in horses. Analytica Chimica Acta. 596(1). 149–155. 24 indexed citations
17.
Leung, Gary N. W., Emmie N. M. Ho, Wai-Him Kwok, et al.. (2007). A bottom-up approach in estimating the measurement uncertainty and other important considerations for quantitative analyses in drug testing for horses. Journal of Chromatography A. 1163(1-2). 237–246. 17 indexed citations
18.
Leung, Gary N. W., et al.. (2006). High throughput screening of sub-ppb levels of basic drugs in equine plasma by liquid chromatography–tandem mass spectrometry. Journal of Chromatography A. 1156(1-2). 271–279. 33 indexed citations
20.
Leung, Gary N. W., et al.. (2001). Analyses of quaternary ammonium drugs in horse urine by capillary electrophoresis – mass spectrometry. Electrophoresis. 22(11). 2201–2209. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026